Senescent secretome shenanigans: Differential therapeutic benefit for breast cancer dictated by distinct extracellular vesicle-mediated inflammatory response
- đ¤ Speaker: Dr Karen Crasta, Principal Investigator at the National University of Singapore, Centre for Healthy Longevity and Department of Physiology.
- đ Date & Time: Thursday 17 October 2024, 13:00 - 14:00
- đ Venue: CRUK CI Lecture Theatre
Abstract
Triple-negative breast cancers, associated with poor prognosis and high tumour recurrence, are often-treated with taxanes in first-line treatment regimens. However, acquired disease resistance often sets in, hampering clinical efficacy. Senescent cells represent a population of residual disease that is highly secretory and drives cancer relapse. Although it is known that therapy-induced senescence can contribute to therapy resistance and cancer relapse via its secretome, the underlying cellular and molecular mechanisms are not fully understood. In this talk, I will discuss a recent study which uncovered an unexpected role for small extracellular vesicles within the senescent tumour cell-derived secretome where they confer critical impact as discrete entities which mediate distinct anti-tumourigenic properties and inflammatory response.
Series This talk is part of the Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer series.
Included in Lists
- All Talks (aka the CURE list)
- Biology
- Cancer Research UK Cambridge Institute (CRUK CI) Seminars in Cancer
- CCC talks for website
- cri
- CRUK CI Lecture Theatre
- CRUK CI Seminars
- Graduate-Seminars
- Liam
- Life Sciences
- Life Sciences
- ME Seminar
- my_list
- other talks
- PMRFPS's
- se393's list
- sfm36
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)

Dr Karen Crasta, Principal Investigator at the National University of Singapore, Centre for Healthy Longevity and Department of Physiology.
Thursday 17 October 2024, 13:00-14:00